Tumor-immune profiling of CT-26 and Colon 26 syngeneic mouse models reveals mechanism of anti-PD-1 response | BMC Cancer | Full Text
sICD inducing chemo-immunotherapy in a mouse model of CT26 colon... | Download Scientific Diagram
Different syngeneic tumors show distinctive intrinsic tumor-immunity and mechanisms of actions (MOA) of anti-PD-1 treatment | Scientific Reports
Frontiers | Combination Foretinib and Anti-PD-1 Antibody Immunotherapy for Colorectal Carcinoma
Immunophenotyping of Tumor-Infiltrating Immune Cells in Mouse Syngeneic Tumor Models Using Multi-Color Flow Cytometry Assays
The CDK4/6 Inhibitor Abemaciclib Induces a T Cell Inflamed Tumor Microenvironment and Enhances the Efficacy of PD-L1 Checkpoint Blockade - ScienceDirect
Different syngeneic tumors show distinctive intrinsic tumor-immunity and mechanisms of actions (MOA) of anti-PD-1 treatment | Scientific Reports
CTLA-4 immunotherapy exposes differences in immune response along with different tumor progression in colorectal cancer | Aging
SubQperior Tumor Models - Reaction Biology
Anti-CTLA-4 and anti-PD-1 immunotherapies repress tumor progression in preclinical breast and colon model with independent regulatory T cells response - ScienceDirect
Engineering high-affinity PD-1 variants for optimized immunotherapy and immuno-PET imaging | PNAS
Antitumor Activities of Immune Costimulatory Molecules of TNF Superfamily in Colorectal and Lung Cancers
CT26 Syngeneic Mouse Model - Altogen Labs
CT26 Xenograft Model | Xenograft Services
a Growth of Sa1N, CT26, ASB-XIV, or MC38 syngeneic tumors was measured... | Download Scientific Diagram
Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap | Nature Communications
Reduced growth of the CT26 colon carcinoma in syngeneic MIF 2/2 mice.... | Download Scientific Diagram
IJMS | Free Full-Text | Chidamide plus Tyrosine Kinase Inhibitor Remodel the Tumor Immune Microenvironment and Reduce Tumor Progression When Combined with Immune Checkpoint Inhibitor in Naïve and Anti-PD-1 Resistant CT26-Bearing Mice
Comparison of cisplatin-induced anti-tumor response in CT26 syngeneic tumors of three BALB/c substrains | Laboratory Animal Research | Full Text
mAb146 significantly inhibited tumor growth in CT-26 syngeneic model.... | Download Scientific Diagram
JCI - Dinaciclib induces immunogenic cell death and enhances anti-PD1–mediated tumor suppression
